Nexavar

DRUG4 trials

Sponsors

Case Comprehensive Cancer Center, Medical University Innsbruck, Yabao Pharmaceutical Group, Fujian Medical University

Conditions

Carcinoma, HepatocellularColorectal CancerFastingHepatocellular CancerNon-small Cell Lung CancerRenal Cell CancerThyroid Cancer, Anaplastic

Early Phase 1

Pilot Study Sorafenib as Bridge to Orthotopic Liver Transplantation (OLT)

TerminatedNCT01337492

Case Comprehensive Cancer CenterCarcinoma, Hepatocellular

Start: 2010-09-30End: 2012-01-31Updated: 2012-03-21

Phase 1

Bioequivalence Study of Sorafenib Tablet and Nexavar

CompletedNCT02599337

Yabao Pharmaceutical GroupFasting

Start: 2015-07-31End: 2015-10-31Updated: 2015-11-06

Phase 2

Nexavar for Neoadjuvant Treatment of Anaplastic Thyroid Cancer

CompletedNCT03565536

Fujian Medical UniversityThyroid Cancer, Anaplastic

Start: 2018-05-01End: 2020-12-30Updated: 2024-04-19

Unknown Phase

Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer Patients

TerminatedNCT01507740

Medical University InnsbruckColorectal Cancer, Hepatocellular Cancer, Non-small Cell Lung Cancer +1

Start: 2009-07-31End: 2014-10-31Updated: 2015-04-29